Long-term efficacy and safety of ustekinumab, with and without dosing adjustment, in patients with moderate-to-severe psoriasis: results from the PHOENIX 2 study through 5 years of follow-up (Q85762151)
Jump to navigation
Jump to search
scientific article published on 22 March 2015
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Long-term efficacy and safety of ustekinumab, with and without dosing adjustment, in patients with moderate-to-severe psoriasis: results from the PHOENIX 2 study through 5 years of follow-up |
scientific article published on 22 March 2015 |
Statements
Long-term efficacy and safety of ustekinumab, with and without dosing adjustment, in patients with moderate-to-severe psoriasis: results from the PHOENIX 2 study through 5 years of follow-up (English)
R G Langley
M Lebwohl
G G Krueger
P O Szapary
Y Wasfi
D Chan
M C Hsu
Y You
Y Poulin
N Korman
J C Prinz
K Reich
PHOENIX 2 Investigators
22 March 2015